The balance sheet reveals growing leverage and a cash burn trend, consistent with the FY2025 net loss reported in the prior 20-F. With the Nasdaq bid-price cure deadline approaching (June 8, 2026), monitor for a potential reverse stock split or delisting notice. The sharp rise in customer deposits may signal increased order activity, but the cash position remains precarious for a $10M market cap company.
Price Chart
Executive Summary
INNEOVA Holdings filed an unaudited interim balance sheet as of March 31, 2026, showing total assets of $50.3M (up 21% from $41.4M at year-end 2025), driven by a surge in accounts receivable and deposits/prepayments. However, total liabilities rose even faster to $44.9M (up 23% from $36.4M), with bank borrowings increasing to $19.1M and customer deposits nearly doubling to $9.6M. Shareholders' equity improved modestly to $5.4M from $5.0M, but the company remains thinly capitalized relative to its debt load, and the prior 20-F reported a net loss for FY2025 with ongoing Nasdaq minimum bid price deficiency risk.
Key Facts
- Total assets increased 21.3% to $50.3M from $41.4M at Dec 31, 2025.
- Total liabilities increased 23.2% to $44.9M from $36.4M, outpacing asset growth.
- Bank borrowings rose to $19.1M from $17.7M, and customer deposits nearly doubled to $9.6M from $5.6M.
- Cash declined to $914K from $1.1M, while accounts receivable (third parties) surged to $11.2M from $7.9M.
- Shareholders' equity is only $5.4M against $44.9M in liabilities, a thin equity cushion.
- The prior 20-F (filed May 15, 2026) reported a net loss of $0.4M for FY2025 vs net income of $0.4M in FY2024, with a 6.9% revenue decline to $58.4M.
- Nasdaq deficiency notice for minimum bid price remains outstanding with cure period through June 8, 2026.
Financial Impact
Balance sheet shows deteriorating liquidity: cash down 13.7% to $0.9M, while short-term debt and customer deposits have grown significantly. The company's net debt (bank borrowings minus cash) stands at $18.2M, up from $16.6M at year-end.
Risk Factors
- Nasdaq delisting risk if minimum bid price not cured by June 8, 2026.
- Thin equity base ($5.4M) relative to $44.9M in total liabilities increases financial vulnerability.
- Cash burn continues with declining cash reserves and rising receivables, potentially requiring additional financing or dilutive capital raise.
- Related-party transactions (significant receivables and payables) add opacity to financial health.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-027386 |
| Document: form6-k.htm | 0001493152-26-027386 |
| Document: 0001493152-26-027386-index-headers.html | 0001493152-26-027386 |
| Document: 0001493152-26-027386-index.html | 0001493152-26-027386 |
| Document: 0001493152-26-027386.txt | 0001493152-26-027386 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $0.5602 $0.5407 | ▲ +3.48% | ▲ +3.90% | $0.5700 (−1.75%) |
Oct 14, 2026 12d ago | 6-K | $0.5445 $0.5602 | ▼ −2.88% | ▼ −3.99% | $0.5700 (−4.68%) |
Sep 4, 2026 7w ago | 6-K | $0.5729 $0.5391 | ▲ +5.90% | ▲ +5.43% | $0.5700 (+0.51%) |
Jun 10, 2026 19w ago | 6-K | $0.6955 $0.6586 | ▲ +5.31% | ▲ +7.01% | $0.5700 (+18.04%) |
Jun 5, 2026 20w ago | 6-K | $0.5502 $0.5355 | ▲ +2.67% | ▲ +2.90% | $0.5700 (−3.60%) |
May 15, 2026 23w ago | 20-F | $0.6340 $0.6280 | ▲ +0.95% | ▲ +0.88% | $0.5700 (+10.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers